510(k) Report

FDA product code · Cardiovascular

Ablation Catheter, Renal Denervation

QYIClass IIIPMA required2 decisions since 20230 recalls

2 FDA decisions since 2023. No recall names this code.

For denervating the renal nerves to lower blood pressure

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of QYI at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QYI

7in 2025

2023: 32024: 132025: 72026 (partial year): 7
2007high 13 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QYI

Too few QYI 510(k)s in any year since 2007 to give a median.

Recalls per year · QYI

No recall names QYI since 2007.

Adverse event reports per year · QYI

14in 2025

2024: 172025: 14
2007high 17 (2024) · low 0 (2007)2025

MAUDE reports naming product code QYI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20233—00
202413—017
20257—014
20267—0—
FIG. 1 — QYI by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QYI? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report